Hereditary Angioedema Market to Demonstrates a Spectacular Growth with CSL Behring, Shire Plc., Pharming Healthcare, Inc., BioCryst Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Arrowhead Pharmaceuticals, Adverum Biotechnologies

Hereditary angioedema (HAE) is characterized by acute skin and mucosal edema caused by an autosomal dominant mutation of the genes. The current treatments of the condition include the HAE drugs which can be administered intravenously, subcutaneously or taken orally. The disease causes swelling particularly of the face and airways and abdominal cramping. The World Allergy Organization (WAO) has set out guidelines to use the different class of drugs such as esterase inhibitors, kallikrein inhibitors and other drugs approved to treat hereditary angioedema.

The global hereditary angioedema market was valued at US$ 1,563.7 million in 2016, and is expected to exhibit a CAGR of 9.1% over the forecast period (2017-2025).

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report @ https://www.stratagemmarketinsights.com/sample/12868

Market Dynamics:

The major factor driving growth of the hereditary angioedema market include intense R&D initiatives by the manufacturers to treat the condition, increasing prevalence of hereditary angioedema and the presence of promising drug pipeline. For instance, in 2017, Attune Pharmaceuticals, revealed the successful study results the first preclinical data results for ATN-249, a novel orally administered plasma kallikrein inhibitor for the treatment of Hereditary Angioedema (HAE).

Also, the approval of novel therapies by the regulatory agencies is expected to be a factor augmenting market growth. For instance, in 2014, the FDA approved Ruconest manufactured by Pharming Healthcare, a recombinant C1-esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with HAE. However, lack of awareness regarding the diseases, inefficient diagnosis and high cost of drugs are the factors restraining hereditary angioedema market growth.

Major players operating in the global hereditary angioedema market include CSL Behring, Shire Plc., Pharming Healthcare, Inc., BioCryst Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Arrowhead Pharmaceuticals, Adverum Biotechnologies, and Attune Pharmaceuticals, Inc.

Frequently Asked Questions:

1. What is the scope of the report?

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.

2. Does this report estimates the current market size?

The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.

3. Does the report provides Market size in terms of - Value (US $ Mn) and Volume (Mn Units)?

The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).

4. Which segments covered in this report?

Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.

5. What are the key factors covered in this report?

The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.

6. Does this report offer customization?

Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Quick Buy – Hereditary Angioedema Market Research Report: https://www.stratagemmarketinsights.com/cart/12868

Table of Contents:

1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations

2. Market Purview
o Report Description
• Market Definition and Scope
o Executive Summary
• Market Snippet, By Drug Class
• Market Snippet, By Route of Administration
• Market Snippet, By Distribution Channel
• Market Snippet, By Region
o Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
• Drivers
• Restraints
• Market Opportunities
o Key Highlights
o Pipeline Analysis
o Regulatory Guidelines
o Epidemiology

4. Global Hereditary Angioedema Market, By Drug Class, 2017 – 2025, (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2025 (%)
• Y-o-Y Growth Analysis, 2017 – 2025
• Segment Trends
o C1 Esterase Inhibitor
o Kallikrein Inhibitor
o Bradykinin Receptor
o Attenuated Androgens
o Others

5. Global Hereditary Angioedema Market, By Route of Administration, 2017 – 2025, (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2025 (%)
• Y-o-Y Growth Analysis, 2017 – 2025
• Segment Trends
o Subcutaneous
o Intravenous
o Oral

6. Global Hereditary Angioedema Market, By Distribution Channel, 2017 – 2025, (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2025 (%)
• Y-o-Y Growth Analysis, 2017 – 2025
• Segment Trends
o Hospital Pharmacies
o Retail Pharmacies
o e-Commerce

7. Global Hereditary Angioedema Market, By Region, 2017 – 2025, (US$ Million)
o Introduction
• Market Share Analysis, By Region, 2016 and 2025 (%)
• Y-o-Y Growth Analysis, For Regions, 2017 – 2025
o North America
• Market Size and Forecast, By Drug Class, 2017 – 2025, (US$ Million)
• Market Size and Forecast, By Route of Administration, 2017 – 2025, (US$ Million)
• Market Size and Forecast, By Distribution Channel, 2017 – 2025, (US$ Million)
• Market Size and Forecast, By Country, 2017 – 2025, (US$ Million)
• U.S.
• Canada
o Latin America
• Market Size and Forecast, By Drug Class, 2017 – 2025, (US$ Million)
• Market Size and Forecast, By Route of Administration, 2017 – 2025, (US$ Million)
• Market Size and Forecast, By Distribution Channel, 2017 – 2025, (US$ Million)
• Market Size and Forecast, By Country, 2017 – 2025, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
o Europe
• Market Size and Forecast, By Drug Class, 2017 – 2025, (US$ Million)
• Market Size and Forecast, By Route of Administration, 2017 – 2025, (US$ Million)
• Market Size and Forecast, By Distribution Channel, 2017 – 2025, (US$ Million)
• Market Size and Forecast, By Country, 2017 – 2025, (US$ Million)
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
o Asia Pacific
• Market Size and Forecast, By Drug Class, 2017 – 2025, (US$ Million)
• Market Size and Forecast, By Route of Administration, 2017 – 2025, (US$ Million)
• Market Size and Forecast, By Distribution Channel, 2017 – 2025, (US$ Million)
• Market Size and Forecast, By Country, 2017 – 2025, (US$ Million)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of APAC
o Middle East
• Market Size and Forecast, By Drug Class, 2017 – 2025, (US$ Million)
• Market Size and Forecast, By Route of Administration, 2017 – 2025, (US$ Million)
• Market Size and Forecast, By Distribution Channel, 2017 – 2025, (US$ Million)
• Market Size and Forecast, By Country, 2017 – 2025, (US$ Million)
• GCC
• Israel
• Rest of Middle East
o Africa
• Market Size and Forecast, By Drug Class, 2017 – 2025, (US$ Million)
• Market Size and Forecast, By Route of Administration, 2017 – 2025, (US$ Million)
• Market Size and Forecast, By Distribution Channel, 2017 – 2025, (US$ Million)
• Market Size and Forecast, By Country, 2017 – 2025, (US$ Million)
• South Africa
• Central Africa
• North Africa

8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis (3×3 Matrix)
o Company Profiles
o Analyst Views

9. Section
o References
o Research Methodology
o About us and Sales Contact

For Any Enquiries/Customization Related Report click Here: https://www.stratagemmarketinsights.com/quiry/12868

Contact Us:

Mr. Shah
Stratagem Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027 / JAPAN +815055391737
Email: sales@stratagemmarketinsights.com
SJ

About Us:

Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with a cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide. Our team includes analysts that leverage their years of experience and expertise to create accurate and error-free reports.

This release was published on openPR.